- Tris Pharma's CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trialPlus, news about Insilico, Ipsen, Q32 Bio, GSK’s Jemperli, Drug Farm and Padcev. ❌ FDA rejects Tris Pharma’s narcolepsy drug: Its rejection letter said that “additional information will be necess…Endpoints · 12d ago↗ source
- STAT+: All eyes on data on Biogen’s tau therapyThe year of daraxonrasib, a wearable for a myeloma drug, and more biotech news from The ReadoutSTAT · 12d ago↗ source
- STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and moreU.S. health secretary Robert F. Kennedy Jr. is pressing forward with his effort to help Americans stop taking SSRI antidepressantsSTAT · 12d ago